메뉴 건너뛰기




Volumn 358, Issue 14, 2008, Pages 1427-1429

Regulating off-label drug use - Rethinking the role of the FDA

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BEVACIZUMAB; GABAPENTIN; METFORMIN; MONTELUKAST; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; RECOMBINANT ERYTHROPOIETIN; ROFECOXIB; TACROLIMUS;

EID: 41649086195     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0802107     Document Type: Article
Times cited : (298)

References (4)
  • 1
    • 85031377160 scopus 로고    scopus 로고
    • Guidance for industry: good reprint practices for the distribution of medical journal articles and medical or scientific reference publications on unapproved new uses of approved drugs and approved or cleared medical devices (draft guidelines). Rockville, MD: Food and Drug Administration, February, 2008. (Accessed March 14, 2008, at http://www.fda.gov/OHRMS/DOCKETS/98fr/ FDA-2008-D-0053-gdl.pdf.)
    • Guidance for industry: good reprint practices for the distribution of medical journal articles and medical or scientific reference publications on unapproved new uses of approved drugs and approved or cleared medical devices (draft guidelines). Rockville, MD: Food and Drug Administration, February, 2008. (Accessed March 14, 2008, at http://www.fda.gov/OHRMS/DOCKETS/98fr/ FDA-2008-D-0053-gdl.pdf.)
  • 3
    • 85031388333 scopus 로고    scopus 로고
    • Adams C, Young A. Risky Rx: a Knight Ridder investigation. Newspaper article series, November 2-4, 2003. (Accessed March 14, 2008, at http://www.mcclatchydc.com/244/story/28122.html.)
    • Adams C, Young A. Risky Rx: a Knight Ridder investigation. Newspaper article series, November 2-4, 2003. (Accessed March 14, 2008, at http://www.mcclatchydc.com/244/story/28122.html.)
  • 4
    • 12444258696 scopus 로고    scopus 로고
    • National trends in cyclooxygenase-2 inhibitor use since market release: Non-selective diffusion of a selectively cost-effective innovation
    • Dai C, Stafford RS, Alexander GC. National trends in cyclooxygenase-2 inhibitor use since market release: non-selective diffusion of a selectively cost-effective innovation. Arch Intern Med 2005;165:171-7.
    • (2005) Arch Intern Med , vol.165 , pp. 171-177
    • Dai, C.1    Stafford, R.S.2    Alexander, G.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.